WAY compared with KLRA: revenue, margins and what each company keeps, and the suppliers and customers both name

WAYWaystar Holding Corp.

Mkt capRevenueRevenue

KLRAKailera Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

WAYWaystar Holding Corp.

KLRAKailera Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

WAYWaystar Holding Corp.

28.00▼−0.74%· post 28.00

Mkt cap$5.4BRevenue$320MQ2 FY26Revenue$1.1BFY25

KLRAKailera Therapeutics, Inc.

12.87▼−4.03%· post 12.67

ClosedOct 30 '26

Mkt cap$1.3BRevenue—Revenue—

Compare

ClosedOct 30 '26

WAYWaystar Holding Corp.

KLRAKailera Therapeutics, Inc.

28.00▼−0.74%post 28.00

Price

12.87▼−4.03%post 12.67

$5.4B

Mkt cap

$1.3B

Q2 FY26$320M

Revenue

—

FY25$1.1B

Revenue

—

WAY28.00▼−0.74%vsKLRA12.87▼−4.03%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

WAY, solidKLRA, dashed

Supply-chain overlap

Revenue flow

KLRA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only WAY 2

PNCPNC Bank, National Associationsupplier

—PNC Capital Marketsunlistedsupplier

Shared 0

No shared counterparties.

Only KLRA 1

—Hengruiunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR